RETRACTION: Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor.

R. Taheri-Ledari, W. Zhang, M. Radmanesh, S. S. Mirmohammadi, A. Maleki, N. Cathcart and V. Kitaev, "Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor," Small 16, no. 41 (2020): 2002733, https://doi.org/10.1002/smll.202002733. The above article, published online on 18 September 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Neville Compton; and Wiley-VCH GmbH. Following publication, concerns were raised by a third-party regarding the appearance of Figures 7d, 11a and 12a. The subsequent investigation uncovered inappropriate duplication of images (panels of Figures 7d and 12a) between this and other articles that were previously published in a different scientific context elsewhere and the manipulation of images in Figure 11a. The investigation also revealed that the animal experiments were neither conducted at, nor received ethical approval from the Department of Nuclear Medicine, West China Hospital, Sichuan University. Given the extent of the identified issues, the editors have decided to retract the article.